Novo Nordisk launches Ozempic in India for diabetes, entry at Rs 2,200/week

• Novo Nordisk launched its anti-type-2 diabetes drug Ozempic (semaglutide injection) in India.
• The entry price for Ozempic is Rs 2,200 per week for the 0.25mg dosage.
• Ozempic is available in 0.25mg, 0.5mg, and 1mg dosages, provided in single-use pre-filled pens.
• Novo Nordisk aims for affordability, pricing Ozempic in the insulin price zone to increase accessibility for Indian patients.
• Ozempic offers significant benefits including HBA1C reduction, up to 15% weight loss, and improved cardiovascular and kidney health.

Why It Matters: Ozempic's launch in India offers a new, affordable diabetes treatment for millions.